Alnylam Adds on Sales, Looks to Pipeline for Further Growth

The biotech could go from one to four marketed drugs in a little over a year. Brian Orelli Aug 12, 2019 at 4:13PM Health Care Alnylam Pharmaceuticals (NASDAQ:ALNY) continued its launch of Onpattro for transthyretin-mediated amyloidosis with solid quarter-over-quarter growth as the biotech looks to its pipeline to further boost its revenue. Alnylam Pharmaceuticals results:…

3 Things You’ll Want to Know About GW Pharmaceuticals’ Sizzling Q2 Results

Fast-growing CBD drug sales powered yet another tremendous quarter for the cannabis-focused biotech. Keith Speights Aug 6, 2019 at 9:30PM Health Care Chalk up another epic quarter for GW Pharmaceuticals (NASDAQ:GWPH). The cannabis-focused biotech posted results in the first quarter that blew past expectations. And GW did it again with the announcement of its second-quarter…

Ionis Pharmaceuticals Looks to Partners to Pay the Bills

Royalties are nice, but licensing, milestone, and option payments are getting it done for this biotech. Brian Orelli Aug 14, 2019 at 1:47PM Health Care Ionis Pharmaceuticals (NASDAQ:IONS) continues to rack up royalties from its spinal muscular atrophy drug Spinraza while the rest of its extensive pipeline basically pays the rest of the biotech’s bills.…

Marketing Targets Achieved with the Help of Artificial Intelligence

Artificial intelligence (AI) has become an integral part of many industries, including marketing. In numerous conducts, AI is already swaying the digital marketing industry, and content marketing is no exception. There is plenty more to come in the future. You can expect numerous AI-based alterations and improvements in the online marketing industry. How Artificial Intelligence…

Why Nektar Therapeutics Stock Is Falling Again Today

The biotech continues to feel the repercussions from news announced last week. Keith Speights Aug 12, 2019 at 12:29PM Health Care What happened Shares of Nektar Therapeutics (NASDAQ:NKTR) had fallen by 11.5% as of 11:31 a.m. EDT on Monday. The biotech stock crashed on Friday, closing 27% lower after revealing in its second-quarter update Thursday evening…

Africa’s top mobile phone seller Transsion to list in Chinese IPO

Chinese mobile-phone and device maker Transsion will list in an IPO on Shanghai’s STAR Market, Transsion confirmed to TechCrunch. The company — which has a robust Africa sales network — could raise up to 3 billion yuan (or $426 million). “The company’s listing-related work is running smoothly. The registration application and issuance process is still…